Pharmacokinetics of saquinavir, zidovudine, and zalcitabine in combination therapy.

We investigated the pharmacokinetics of zidovudine, zalcitabine, and saquinavir in AIDS Clinical Trial Group protocol 229. Patients received either saquinavir, zalcitabine, or a combination of both, together with zidovudine three times a day. Approximately 100 patients were enrolled in each treatmen...

Celý popis

Podrobná bibliografie

Vydáno v:	Antimicrob Agents Chemother
Hlavní autoři:	Vanhove, G F, Kastrissios, H, Gries, J M, Verotta, D, Park, K, Collier, A C, Squires, K, Sheiner, L B, Blaschke, T F
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	American Society for Microbiology (ASM) 1997
Témata:	Research Article
On-line přístup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC164140/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9371345/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.41.11.2428
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!